Mahalpure, S., G. S. Mahalpure, V. Daga, and H. Nehete. “A Review on Resmetirom: An Oral Thyroid Hormone Receptor-β Agonist for the Treatment of Metabolically Dysfunction-Associated Steatohepatitis (MASH)”. Journal of Pharmaceutical and Biopharmaceutical Research, Vol. 8, no. 1, July 2026, pp. 551-68, doi:10.25082/JPBR.2026.01.002.